Literature DB >> 9094719

The G beta gamma sensitivity of a PI3K is dependent upon a tightly associated adaptor, p101.

L R Stephens1, A Eguinoa, H Erdjument-Bromage, M Lui, F Cooke, J Coadwell, A S Smrcka, M Thelen, K Cadwallader, P Tempst, P T Hawkins.   

Abstract

Two highly similar, PtdIns(4,5)P2-selective, G beta gamma-activated PI3Ks were purified from pig neutrophil cytosol. Both were heterodimers, were composed of a 101 kDa protein and either a 120 kDa or a 117 kDa catalytic subunit, and were activated greater than 100-fold by G beta gammas. Peptide sequence-based oligonucleotide probes were used to clone cDNAs for the p120 and p101 species. The cDNA of p120 is highly related to p110 gamma, while the cDNA of p101 is not substantially related to anything in current databases. The proteins were expressed in and purified from insect and mammalian cells. They bound tightly to one another, both in vivo and in vitro, and in so doing, p101 amplified the effect of G beta gammas on the PI3K activity of p120 from less than 2-fold to greater than 100-fold.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9094719     DOI: 10.1016/s0092-8674(00)80187-7

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  151 in total

1.  Gi-mediated translocation of GLUT4 is independent of p85/p110alpha and p110gamma phosphoinositide 3-kinases but might involve the activation of Akt kinase.

Authors:  L Wang; H Hayashi; K Kishi; L Huang; A Hagi; K Tamaoka; P T Hawkins; Y Ebina
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

2.  Polarization of chemoattractant receptor signaling during neutrophil chemotaxis.

Authors:  G Servant; O D Weiner; P Herzmark; T Balla; J W Sedat; H R Bourne
Journal:  Science       Date:  2000-02-11       Impact factor: 47.728

3.  Evidence that a protein-protein interaction 'hot spot' on heterotrimeric G protein betagamma subunits is used for recognition of a subclass of effectors.

Authors:  J K Scott; S F Huang; B P Gangadhar; G M Samoriski; P Clapp; R A Gross; R Taussig; A V Smrcka
Journal:  EMBO J       Date:  2001-02-15       Impact factor: 11.598

4.  Comparison of the kinetic properties of the lipid- and protein-kinase activities of the p110alpha and p110beta catalytic subunits of class-Ia phosphoinositide 3-kinases.

Authors:  C A Beeton; E M Chance; L C Foukas; P R Shepherd
Journal:  Biochem J       Date:  2000-09-01       Impact factor: 3.857

Review 5.  Phosphatidylinositol 3' kinase signaling in mammary tumorigenesis.

Authors:  M P Scheid; J R Woodgett
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-01       Impact factor: 2.673

6.  Mechanism of the regulation of type IB phosphoinositide 3OH-kinase byG-protein betagamma subunits.

Authors:  Sonja Krugmann; Matthew A Cooper; Dudley H Williams; Phillip T Hawkins; Len R Stephens
Journal:  Biochem J       Date:  2002-03-15       Impact factor: 3.857

Review 7.  Chemokine signalling: pivoting around multiple phosphoinositide 3-kinases.

Authors:  Adam P Curnock; Marisa K Logan; Stephen G Ward
Journal:  Immunology       Date:  2002-02       Impact factor: 7.397

8.  Cannabinoid CB1 receptors transactivate multiple receptor tyrosine kinases and regulate serine/threonine kinases to activate ERK in neuronal cells.

Authors:  George D Dalton; Allyn C Howlett
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

9.  Defective dendritic cell migration and activation of adaptive immunity in PI3Kgamma-deficient mice.

Authors:  Annalisa Del Prete; William Vermi; Erica Dander; Karel Otero; Laura Barberis; Walter Luini; Sergio Bernasconi; Marina Sironi; Amerigo Santoro; Cecilia Garlanda; Fabio Facchetti; Matthias P Wymann; Annunciata Vecchi; Emilio Hirsch; Alberto Mantovani; Silvano Sozzani
Journal:  EMBO J       Date:  2004-08-19       Impact factor: 11.598

Review 10.  G-protein signaling: back to the future.

Authors:  C R McCudden; M D Hains; R J Kimple; D P Siderovski; F S Willard
Journal:  Cell Mol Life Sci       Date:  2005-03       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.